As you take your health app from innovative idea to reality, you will be engaging in a development project that will likely entail the procurement of technology, services and perhaps even content from third parties. For example, you may hire an app developer. Or perhaps you will take advantage of a cloud-based hosting platform that enables you to build a secure health app leveraging a third party’s infrastructure, such as Amazon or Google. Perhaps your app will integrate patient education content from a medical publisher or rely on analytics from an industry data aggregator. Careful contracting with third parties who provide these services and components will be critical to your health app’s success. This fifth installment of our series will outline contracting principles for the construction of a health app. Continue Reading Building a Health App? Part 5: Contracting for Health App Construction
This post is the second in a series of weekly blog posts covering legal issues for consideration during the early stages of development of a health app and providing best practices to help guide you through a successful launch. Consideration of intellectual property (IP) protection early in the development of a health app is important. Otherwise you could lose the opportunity to do so in the future or be forced to change the name or other details of your app after you have already invested time and money in the app.
Last week, Apple announced the new Apple Watch Series 3 which will feature an enhanced heart rate app. The app will notify you when it detects an elevated heart rate even when you are not working out. The sensor will also be able to analyze cardiac arrhythmia. According to one estimate, 165,000 health-related apps were available for Apple or Android smartphones last year. Forecasts predict that such apps will be downloaded 1.7 billion times by 2017. Without a doubt, health apps are turning into a big business presenting not only an opportunity for financial success but the potential to impact the health and wellness of millions of consumers. The success of a health app will depend on careful consideration of some key legal issues during the early stages of development. In a series of weekly blog posts, we will cover these issues and provide best practices to help guide you through the successful launch of your health app. Below is a preview of what this series will cover. Continue Reading Building a Health App? What You Need to Know
Mintz Levin is running a series of webinars to educate our clients and friends on developments in the biosimilars space. A cross-practice team of professionals from the IP, Health and Litigation sections are collaborating to present on Patent Prosecution, Health Regulatory, FDA, Patent Litigation, Transactional and Products Liability issues. Anyone working in the biotechnology space, as well as pharmacy payors and health care providers who may be administering or dispensing biosimilars to their patients, will be interested in these presentations. The first webinar on January 7, 2016 will provide a legal and regulatory overview of the biosimilars industry and will feature Terri Shieh-Newton, PhD, and Joanne Hawana.
Part II: FDA/Regulatory — January 28 | 3:00 pm ET
Part III: BPCIA Patent Litigation — February 25 | 3:00 pm ET
Part IV: Transactions and Patent Portfolios — March 17 | 3:00 pm ET
Part V: Post-Market Legal and Regulatory Issues — April 7 | 3:00 pm ET